Clinical Trial Update: Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen [Phase 2]

View source ↗

Summary

Phase 2 multi-center study evaluated a myeloablative allogeneic stem cell transplant using the CloBu4 regimen for non-remission acute myeloid leukemia; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (clofarabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Acute Myeloblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-07-25